David Zhang

Assistant Professor

Columbia University Irving Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

David Zhang is an Assistant Professor at Columbia University Medical Center in the United States. His research primarily focuses on interstitial lung diseases, pulmonary fibrosis, and the genetic underpinnings of these conditions. He has contributed significantly to the understanding of clinical biomarkers and the implications of telomere length in lung disease prognosis. Dr. Zhang's recent articles highlight his expertise in imaging, genetic associations, and post-infectious pulmonary complications.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

David Lederer

Regeneron Pharmaceuticals

UNITED STATES

View details

Columbia University Irving Medical Center

UNITED STATES

View details

Raphael Borie

INSERM

FRANCE

View details

Vaidehi Jobanputra

Columbia University Irving Medical Center

UNITED STATES

View details

University of Chicago Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Zhang

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Associations of High Attenuation Area–Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities

Genetic Associations in Non-Europeans with Pulmonary Fibrosis: Analysis of the All of Us Cohort

Genetics of interstitial lung diseases: a state-of-the-art review

Imaging, Pulmonary Function, and Histopathologic Findings of Persistent Fibrosis in a Longitudinal Cohort 3-Years after COVID-19

Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation.

Post-infectious Pulmonary Complications: Establishing Research Priorities to Advance the Field. An Official American Thoracic Society Workshop Report

Clinical Impact of Telomere Length Testing for Interstitial Lung Disease

Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease

Telomere Length and Immunosuppression in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease

Radiographic Lung Abnormalities in First-Degree Relatives of Patients With Different Subtypes of Pulmonary Fibrosis

Performance of GAP and ILD-GAP models in predicting lung transplant or death in interstitial pneumonia with autoimmune features.

Incidence of interstitial lung abnormalities: the MESA Lung Study

Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts

Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis

Genome-wide Enrichment of <i>TERT</i> Rare Variants in IPF Patients of Latino Ancestry

Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry

Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis

Rare and Common Variants in KIF15 Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis

Collaborators (14)

David Lederer

RILEY HANNAN

Joseph Garcia

Sushilkumar Sonavane

Julia Kozlitina

Amali Samarasinghe

Anna Podolanczuk

Elana J Bernstein

Raphael Borie

Vaidehi Jobanputra

Christine Kim Garcia

Ayodeji Adegunsoye

Toby Maher

Cathryn Lee

Make your next move.